Aculeacin A is a lipopeptide that inhibits ,B-glucan synthesis in yeasts. A number of Saccharomyces cerevisiae mutants resistant to this antibiotic were isolated, and four loci (ACRI, ACR2, ACR3, and ACR4) whose products are involved in the sensitivity to aculeacin A of yeast ceils were defined. Mutants containing mutations in the four loci were also resistant to echinocandin B, another member of this lipopeptide family of antibiotics. In contrast, acri, acr3, and acr4 mutants were resistant to papulacandin B (an antibiotic containing a disaccharide linked to two fatty acid chains that also inhibits P-glucan synthesis), but acr2 mutants were susceptible'to this antibiotic. This result defines common and specific steps in the entry and action of aculeacin A and papulacandin B. The analysis of double mutants revealed an epistatic effect of the acr2 mutation on the other three mutations. Cell walls of the four different mutants did not show significant alterations in composition with respect to the parental strain, and in vitro glucan synthase activity was also unaffected. However, cell surface hydrophobicity in three of the mutants was considerably decreased with respect to the parental strain.
P-Glucan is the main structural component of the yeast cell wall, to which it confers its characteristic rigidity (1, 10) .
A number of antibiotics are inhibitors of P-glucan synthesis in yeast species (8) . In their presence, the cell wall structure becomes destabilized and cell lysis occurs unless the medium is protected osmotically. Papulacandin B is an amphiphilic molecule with a hydrophilic moiety consisting of glucose and galactose and a hydrophobic moiety containing two long-chain unsaturated fatty acids (2) . It has been shown that papulacandin B specifically reduces the levels of p-glucan in the cell walls of a number of yeasts (2, 8, 36) . On the other hand, synthesis of a-glucan (which is a major component of Schizosaccharomyces pombe cell walls [51) is not inhibited by papulacandin B (36) . Another family of p-glucan inhibitors comprises aculeacin A, echinocandin B, and cilofungin (LY121019), among others; they contain a cyclopeptide moiety linked to a fatty acid chain. Several studies have demonstrated that in the presence of one of these lipopeptide antibiotics, synthesis of p-glucan is affected in vivo in yeast species such as Saccharomyces cerevisiae, Candida albicans, and S. pombe (12, 20, 21, 28, 33, 37, 38) . Indirectly, incorporation of mannoproteins into the walls of yeast cells treated with aculeacin A or papulacandin B is also inhibited (22, 35) .
The exact mechanism of action of these antibiotics is not well understood. In vitro, high concentrations of papulacandin B inhibit j3-1,3-glucan synthase activity in extracts from S. pombe or Geotrichum candidum (25, 36) , but this antibiotic has been observed to be ineffective on extracts from S. cerevisiae (8, 11) . Echinocandin B (28) and cilofungin (33, 34) are noncompetitive inhibitors of the glucan synthase activity of C. albicans, although in our laboratory neither aculeacin A nor echinocandin B inhibits S. cerevisiae P-1,3-glucan synthase activity (11) when a conventional in vitro assay for this enzyme (29, 32) is employed. In S. cerevisiae and C. albicans, glucan synthase is found at the plasma membrane (24, 29, 32) . It is reasonable that in vivo inhibition of P-glucan synthesis might be a consequence of the direct interaction of the antibiotic with the synthase; alternatively, it may be due to some indirect effect. The lipid moiety of the lipopeptide antibiotics plays an important role in their mechanism of action, probably by establishing specific interactions with the membrane (34) , and its role in the transport of the antibiotic through the cell wall and/or plasma membrane should also be considered. In this context, it can be noted that although cilofungin differs from aculeacin A and echinocandin B exclusively in the fatty acid moiety (6), cultures of two independent S. cerevisiae wild-type strains were resistant to cilofungin at 100 ,ug/ml but not to aculeacin A or echinocandin B (11 Isolates LMF1l1 to LMF106 of the a mating type were crossed with the parental strain. All of the resulting diploids were sensitive to aculeacin A (Table 1) ; thus, the resistance mutations are recessive.
Aculeacin A had a variable effect on growth rate depending on the mutant strain and the presence or absence of sorbitol in the growth medium (Fig. 1) . LMF1l1 was the most affected strain; its growth rates with respect to control cultures without the antibiotic were about 45% in YPD medium and 80% in YPDS medium. The growth defect of strain LMF106 in YPD medium plus aculeacin A was also significantly reversed by the osmotic stabilizer (Fig. 1) .
The six mutant strains did not exhibit gross morphological alterations with respect to the parental strain. However, cultures of LMF1O1 and LMF106 in the absence of sorbitol contained a certain number of lysed cells, which were not observed in the presence of the stabilizer. Cultures of the other mutants were free of lysed cells under all growth conditions. Several other phenotypic traits of the mutant strains were studied ( Table 1 ). The MIC of aculeacin A varied among strains, being at least 10-fold higher than the value of the parental strain. All six mutants were also resistant to echinocandin B. However, while mutants LMF1l1, LMF105, and LMF106 were also resistant to papulacandin B, strains LMF102, LMF103, and LMF104 were susceptible to this antibiotic.
Extraceliular stability of the antibiotic molecules. Resistance in the mutants is not caused by extracellular degradation of the antibiotic, since cell-free supernatant fluids obtained from 6-h cultures of the mutants grown in the presence of aculeacin A (5 ,ug/ml) were still able to inhibit growth of the wild-type strain (11) .
Determination of the number of genetic loci defined by mutants LMFlOl to LMF106. We constructed all possible diploids by mating all possible pairs of mutants; in each of the mating experiments, one of the mutants was HIS3 ade2 while the other was his3 ADE2. The 15 diploids were then sporulated. Both random spore analysis experiments (using the recessive ade2 marker as the indicator of haploid colonies [see reference 30] ) and tetrad analysis indicated that the resistance mutations carried by LMF102, LMF103, and LMF104 affect the same locus or closely linked loci. In fact, TIME (HOURS) no haploid-sensitive spores could be derived from crosses between these mutants. On the other hand, random spore analysis resulted in a segregation pattern close to 3:1 for the aculeacin A resistance: susceptibility character in crosses among LMF101, LMF105, and LMF106 or between one of these mutants and one from the group consisting of LMF102, LMF103, and LMF104, indicating that these mutants carry independent mutations in separate chromosomes. To confirm this, tetrad analyses of the same crosses resulted in parental ditypes (4:0 segregation pattern for resistance and susceptibility to aculeacin A), nonparental ditypes (2:2), and tetratypes (3:1).
Thus, at least four different genes are defined by the six mutants characterized in this work: ACRI (defined by LMF101), ACR2 (defined by LMF102), ACR3 (defined by LMF105), and ACR4 (defined by LMF106).
Epistatic effects among acr mutations. Double acr mutants were recovered from the aculeacin A-resistant spores present in nonparental ditype tetrads obtained by crossing single acr mutants. Two differential phenotypic traits (susceptibility to papulacandin B and effect of sorbitol on growth rate) of the double mutants were analyzed ( Table 2 ). The mutation in acr2 is epistatic to mutations in the other loci, and the acr3 mutation is also epistatic to acri and acr4.
Cell wall composition in aculeacin A-resistant mutants. The amount of cell wall sugar was not severely affected in the strains carrying the four acr mutations in comparison with the wild type (Table 3) . However, the in vivo incorporation of radioactivity into the walls of mutant cells was not affected by the antibiotic, while the level of inhibition was 96% in the wild type. As expected, incorporation into the alkali-and acid-insoluble fra4tion (P-glucan) was most affected in the wild-type strain. Fractionation of wall polysaccharides from the mutants yielded a pahtern not significantly different from that of the wild type, ind the presence of aculeacin A in the mutant cultures did not have an important effect on the relative percentages (Table 3 ).
In vitro P-1,3-glucan synthase activity in the acr mutants as well as in the parental strain was measured ( Table 4 ). All of the strains had similar levels of GTP-or ATP-activable glucan synthase activity. Both in the parental and in the mutant strains, aculeacin A and papulacandin B (at concentrations up to 20 ,ug/ml in the assay mixture) and echonocandin B (up to 40 jxg/ml) did not have an inhibitory effect in vitro (11) .
Effect of aculeacin A and papulacandin B on regenerating protoplasts. Incorporation of radioactivity into cell wall polysaccharides in regenerating protoplasts of the parental and acr strains was sensitive to acule,acin A and papulacandin B (30 to 60% of the level of incorporation in the control). The different polysaccharide fractions were affected to similar extents by the antibiotics (11) , in accordance with previous observations with wild-type yeasts (22, 35) .
CSH in mutant cells. CSH values for the parental and mutant strains were determined by the phase partition test (28) and the microsphere hydrophobicity assay (14) . Strains with the acri, acr3, or acr4 mutation had CSH values of less than half of the parental value (Table 5 ). In contrast, the parental strain and the acr2 mutant had similar CSH values when CSH was measured by the phase partition test; when CSH was determined by the microsphere hydrophobicity assay, acr2 cells displayed a CSH value intermediate be- tween that of the parental strain and those of the other three mutants.
Resistance to aculeacin A and resstance to papulac n B are not necesarily correlated. The properties of the four acr mutants described above indicate that acquisition of resistance to aculeacin A does not imply resistance to papulacandin B in parallel. That is, some of the physiological functions involved in the action of both antibiotics seem to be common to both drugs, while others are different for each drug. To confirm this, a collection of mutants resistant to papulacandin B (10 ,ug/ml) was obtained by the same protocol used for aculeacin A. Of 15 independently obtained mutants, 10 were also resistant to aculeacin A, while the other 5 showed the same levels of susceptibility to this antibiotic as the parental OLl strain.
DISCUSSION
A mutant of C. albicans simultaneously resistant to papulacandin B and echinocandin B had been isolated previously (2), and another C. albicans strain obtained as resistant to aculeacin A showed cross-resistance to papulacandin B (19) . A collection of S. pombe papulacandin B-resistant (26) , and some of them are still susceptible to aculeacin A. In the present work with S. cerevisiae mutants, we have shown that resistance to aculeacin A does not necessarily correlate with resistance to papulacandin B, that is, there are common and specific steps in the mechanisms of entry and action of these antibiotics. The functions defined by ACR1, ACR3, and ACR4 are required for cell sensitivity to both families of antibiotics. In turn, the physiological function defined by ACR2 is necessary for the sensitivity of cells to aculeacin A although not to papulacandin B. Interestingly, double mutants with mutations in ACR2 and in one of the other three ACR loci are also sensitive to papulacandin B; since single mutants with mutations in ACR1, ACR3, or ACR4 are resistant to this antibiotic, the ACR2 function must remain unaltered for the effect of papulacandin B to be blocked.
None of the four mutants exhibits gross alterations in cell wall polysaccharide composition. The mutants contain normal levels of GTP-or ATP-activable 3-1,3-glucan synthase activity. This argues against the synthase being directly altered in any of the acr mutants. Obviously, the possibility of the existence of more than one activity involved in the synthesis of 3-1,3-glucan in S. cerevisiae, in a manner similar to chitin synthesis (4, 23, 31) , must be comtemplated. Synthesis of ,B-1,3-glucan probably is a complex process in which many different cellular functions are involved.
Since protoplasts from the four independent acr mutants are sensitive to aculeacin A and papulacandin B, the mutations probably affect cell surface structures or functions involved in the accessibility of the antibiotic molecules to the plasma membrane. However, we should not completely discard the alternative possibility that the physiological functions affected by aculeacin A or papulacandin B in regenerating protoplasts do not exactly correspond to those affected in whole cells; in this respect, the inhibitory effect of aculeacin A was much less pronounced on protoplasts than on whole cells in the parental strain. Having considered this, we still favor the suggestion that the acr mutations alter entry of the antibiotic molecules into whole cells.
The fact that the three mutants resistant to both aculeacin A and papulacandin B exhibit lower CSH values than the wild-type strain points to the importance of surface charge in the accessibility of the target to the antibiotic molecules. Several observations suggest that changes in yeast cell wall proteins are responsible for the modifications in surface hydrophilicity and hydrophobicity (15, 18) . Thus, antibiotic resistance in the mutants described above may derive more from fine changes in the wall mannoprotein pattern that alter CSH than from the overall polysaccharide composition. CSH may participate, together with other mechanisms, in the adherence of C. albicans to surfaces in vivo, contributing to the virulence of this yeast species (13, 17) . Therefore, isolation of aculeacin A-and papulacandin B-resistant mutants can be a strategy for obtaining C. albicans strains with decreased virulence and for studying the basis of pathogenicity in this yeast species.
